Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trial
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference36 articles.
1. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States;Wolf-Maier;JAMA,2003
2. Comparison of the blood pressure-lowering effects and tolerability of losartan- and amlodipine-based regimens in patients with isolated systolic hypertension;Volpe;Clin Ther,2003
3. Characteristics of patients with uncontrolled hypertension in the United States;Hyman;N Engl J Med,2001
4. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report [published correction appears in JAMA. 2003:290:197];Chobanian;JAMA,2003
5. The calcium antagonists in the 1990s. An overview;Oparil;Am J Hypertens,1991
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy;Medicine;2018-09
2. Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects;Drug Design, Development and Therapy;2015-06
3. Uptitrating amlodipine significantly reduces blood pressure in diabetic patients with hypertension: a retrospective, pooled analysis;Vascular Health and Risk Management;2014-11
4. Comparative Effect of Racemic Amlodipine and its Enantiomer with Atenolol on Hypertensive Patients—A Randomized, Open, Parallel Group Study;Journal of Experimental & Clinical Medicine;2013-12
5. Blood pressure responder rates versus goal rates: which metric matters?;Therapeutic Advances in Cardiovascular Disease;2009-01-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3